DK0736532T3 - Pyrido[3,2-e]pyrazinoner med antiastmatisk virkning og fremgangsmåde til deres fremstilling - Google Patents

Pyrido[3,2-e]pyrazinoner med antiastmatisk virkning og fremgangsmåde til deres fremstilling

Info

Publication number
DK0736532T3
DK0736532T3 DK96103855T DK96103855T DK0736532T3 DK 0736532 T3 DK0736532 T3 DK 0736532T3 DK 96103855 T DK96103855 T DK 96103855T DK 96103855 T DK96103855 T DK 96103855T DK 0736532 T3 DK0736532 T3 DK 0736532T3
Authority
DK
Denmark
Prior art keywords
pyrazinones
pyrido
preparation
asthmatic action
asthmatic
Prior art date
Application number
DK96103855T
Other languages
Danish (da)
English (en)
Inventor
Norbert Dr Hoefgen
Thomas Dr Buechner
Ute Dr Achterrath-Tuckermann
Stefan Prof Szelenyi
Bernhard Prof Kutscher
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0736532T3 publication Critical patent/DK0736532T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96103855T 1995-03-24 1996-03-12 Pyrido[3,2-e]pyrazinoner med antiastmatisk virkning og fremgangsmåde til deres fremstilling DK0736532T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510965A DE19510965A1 (de) 1995-03-24 1995-03-24 Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
DK0736532T3 true DK0736532T3 (da) 2002-09-02

Family

ID=7757727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96103855T DK0736532T3 (da) 1995-03-24 1996-03-12 Pyrido[3,2-e]pyrazinoner med antiastmatisk virkning og fremgangsmåde til deres fremstilling

Country Status (30)

Country Link
US (1) US5723463A (no)
EP (1) EP0736532B1 (no)
JP (1) JP4124280B2 (no)
KR (1) KR100401395B1 (no)
CN (1) CN1058968C (no)
AR (1) AR002039A1 (no)
AT (1) ATE217624T1 (no)
AU (1) AU697908B2 (no)
BR (1) BR9601093A (no)
CA (1) CA2172472C (no)
CZ (1) CZ290784B6 (no)
DE (2) DE19510965A1 (no)
DK (1) DK0736532T3 (no)
ES (1) ES2174989T3 (no)
HR (1) HRP960129B1 (no)
HU (1) HUP9600731A3 (no)
IL (1) IL117621A (no)
MX (1) MX9601069A (no)
NO (1) NO307091B1 (no)
NZ (1) NZ286232A (no)
PL (1) PL184800B1 (no)
PT (1) PT736532E (no)
RU (1) RU2143433C1 (no)
SG (1) SG43249A1 (no)
SI (1) SI0736532T1 (no)
SK (1) SK36596A3 (no)
TR (1) TR199600217A2 (no)
TW (1) TW426682B (no)
UA (1) UA45319C2 (no)
ZA (1) ZA962270B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
KR20010101603A (ko) * 1999-01-20 2001-11-14 노왈드 이미다조[1,5-ａ]-피리도[3,2-ｅ]-피라지논의 약제로서의용도
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
EP2103613B1 (en) 2006-12-13 2016-02-17 ASKA Pharmaceutical Co., Ltd. Quinoxaline derivative
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EA019085B1 (ru) 2007-09-14 2014-01-30 Янссен Фармасьютикалз, Инк. 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
NZ584145A (en) 2007-09-14 2012-03-30 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones
EP2205565B1 (en) * 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
MX2010005110A (es) * 2007-11-14 2010-09-09 Ortho Mcneil Janssen Pharm Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
EP2227472A1 (en) * 2007-11-30 2010-09-15 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
AU2008329775A1 (en) 2007-11-30 2009-06-04 Biotie Therapies Gmbh Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
MX2011005242A (es) 2008-11-28 2011-09-06 Ortho Mcneil Janssen Pharm Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
CA2760259C (en) 2009-05-12 2018-05-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5166344A (en) * 1989-05-31 1992-11-24 Berlex Laboratories, Inc. Process for the preparation of imidazoquinoxalinones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
WO1992022552A1 (en) * 1991-06-14 1992-12-23 The Upjohn Company IMIDAZO[1,5-a]QUINOXALINES
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ３環性トリアゾロ誘導体の製造方法
JP3252484B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ４，５−ジヒドロ［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体の製造方法
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CN1041931C (zh) * 1993-05-06 1999-02-03 诺沃-诺迪斯克有限公司 [1,2,4]三唑并[4,3－a]喹喔啉化合物,它们的制备及其应用
CA2112290C (en) * 1993-12-23 2004-06-01 John R. Francis A clock recovery circuit for serial digital video
JP3240462B2 (ja) * 1996-05-24 2001-12-17 株式会社ケンウッド 光ディスク装置の光ピックアップサーボ装置

Also Published As

Publication number Publication date
US5723463A (en) 1998-03-03
ZA962270B (en) 1996-09-30
PL313434A1 (en) 1996-09-30
IL117621A (en) 1999-05-09
EP0736532B1 (de) 2002-05-15
ATE217624T1 (de) 2002-06-15
CA2172472C (en) 2000-01-18
CN1058968C (zh) 2000-11-29
SK36596A3 (en) 1997-02-05
HU9600731D0 (en) 1996-05-28
HRP960129A2 (en) 1997-08-31
TR199600217A2 (tr) 1996-10-21
NZ286232A (en) 1996-10-28
EP0736532A1 (de) 1996-10-09
HUP9600731A2 (en) 1997-01-28
SG43249A1 (en) 1997-10-17
CZ290784B6 (cs) 2002-10-16
BR9601093A (pt) 1998-01-06
IL117621A0 (en) 1996-07-23
CZ74796A3 (en) 1996-10-16
KR100401395B1 (ko) 2003-12-24
UA45319C2 (uk) 2002-04-15
AR002039A1 (es) 1998-01-07
RU2143433C1 (ru) 1999-12-27
HUP9600731A3 (en) 1997-04-28
PT736532E (pt) 2002-10-31
AU697908B2 (en) 1998-10-22
KR960034204A (ko) 1996-10-22
JP4124280B2 (ja) 2008-07-23
ES2174989T3 (es) 2002-11-16
NO307091B1 (no) 2000-02-07
HRP960129B1 (en) 2002-12-31
JPH08269059A (ja) 1996-10-15
NO961173D0 (no) 1996-03-22
CN1140173A (zh) 1997-01-15
PL184800B1 (pl) 2002-12-31
TW426682B (en) 2001-03-21
CA2172472A1 (en) 1996-09-25
DE59609201D1 (de) 2002-06-20
NO961173L (no) 1996-09-25
SI0736532T1 (en) 2002-08-31
AU4825796A (en) 1996-10-03
MX9601069A (es) 1997-02-28
DE19510965A1 (de) 1996-09-26

Similar Documents

Publication Publication Date Title
DK0736532T3 (da) Pyrido[3,2-e]pyrazinoner med antiastmatisk virkning og fremgangsmåde til deres fremstilling
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
ZA9710256B (en) Methods and compositions for stimulating neurite growth.
PL314635A1 (en) Derivatives of pyrimidinodione, pyrimidinotrione, triazinodione and tetrahydroquinazolinodione and method of obtaining them
HK1123280A1 (en) N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
ZA9710248B (en) Methods and compositions for stimulating neurite growth.
ZA9710258B (en) Methods and compositions for stimulating neurite growth.
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
ZA967513B (en) Method of treating insulin resistance.
NO975977D0 (no) Substituerte purinderivater, fremgangsmåter for fremstilling og anvendelse derav
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
DK0909270T3 (da) Fremgangsmåde til fremstilling af 2,4-dihydroxypyridin og 2,4-dihydroxy-3-nitropyridin
NO943794L (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
HU9700595D0 (en) Fluoro-alkyl- and fluoro-alkoxy-substituted heterocyclic bradiquinine-antagonists, process for producing them and their use
HUP9602332A2 (en) Method of preparing 4,6-dichloro pyrimides
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
AU1260597A (en) Method of platinum recovery
DK0838469T3 (da) 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
DE58900795D1 (de) Verfahren und system zum einstellen des lambda-wertes.
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
IL126539A (en) Pregnane derivatives with no alpha-17 substituent, their medicinal use and manufacturing method
IS4957A (is) Hreinsuð prótein, samskeyttar DNA raðir og aðferðir til að stýra þroskun kaffiplantna
IL126105A (en) Furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
DK0726250T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåder til deres fremstilling og deres anvendelse til